Glycodiazine or glymidine

This classification denotes an antimuscarinic agent with the molecular formula C19H28NO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier A14FB57V1D, chemically known as 3-hydroxy-1,1-dimethylpyrrolidinium bromide .alpha.-cyclopentylmandelate but generally known as glycopyrrolate, which bears US NIH Compound Identifier 3494. European Medicines Agency schedules Glycopyrronium in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB02381MIG. The term GLYCOPYRRONIUM BROMIDE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 19 1975, List 5). World Health Organization schedules glycopyrrolate in its Anatomical Therapeutic Chemical (ATC) Classification. As of Q4 2014, GLYCOPYRROLATE remains the US FDA Preferred Term for this commodity. Glycopyrrolate bears US NLM identifiers UMLS ID C0017970 and NCI Concept Code C29078. SMILES: C[N+]1(CCC(C1)OC(=O)C(C2CCCC2)(C3=CC=CC=C3)O)C.